Mid/Small Cap AI Study of the Week
October 10, 2024
Weekly AI Study from the S&P 400 or S&P 600
Company Overview
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative immuno-oncology therapies that aim to restore the immune system's ability to fight cancer. The company focuses on
